title: Rituximab in the management of chronic immune thrombocytopenic purpura: what is its place?
authors: Stéphane
authors: S
authors: Ducassou
authors: Nathalie
authors: N
authors: Aladjidi
authors: Patrick
authors: P
authors: Lutz
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000601:surgery; D012189:Retrospective Studies; D000069283:Rituximab; D013156:Splenectomy
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab